Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
1-NITROSOIMIDAZOLIDINONE |
EINECS | N/A |
CAS No. | 3844-63-1 | Density | 1.72g/cm3 |
PSA | 61.77000 | LogP | -0.04030 |
Solubility | N/A | Melting Point |
101.65°C |
Formula | C3H5 N3 O2 | Boiling Point | °Cat760mmHg |
Molecular Weight | 115.092 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intraperitoneal and subcutaneous routes. Mutation data reported. Questionable carcinogen with experimental tumorigenic data. Many N-nitroso compounds are carcinogens. When heated to decomposition it emits toxic fumes of NOx. See also N-NITROSO COMPOUNDS. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
1-Nitroso-2-imidazolidinone;1-Nitroso-2-imidazolidone; Ethylenenitrosourea; N-Nitroso-2-imidazolidone;N-Nitrosoimidazolidone; NSC 73438 |
Article Data | 3 |
1. | mmo-sat 16 µmol/L/48H | MUREAV Mutation Research. 48 (1977),131. | ||
2. | mmo-smc 400 mg/L/30M | GENTAE Genetics. 78 (1974),1101. | ||
3. | mrc-smc 5 mmol/L | ZEVBA5 Zeitschrift fuer Verebungslehre. 98 (1966),230. | ||
4. | scu-rat LD50:250 mg/kg | ZEKBAI Zeitschrift fuer Krebsforschung. 69 (1967),103. | ||
5. | ipr-mus LD50:28,200 µg/kg | NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . |